BELGRADE, Mont., Aug. 24, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has been invited to present at the Stifel Nicolaus 2011 Healthcare Conference. The conference will be held at the Four Seasons Hotel in Boston, Massachusetts on September 7-9, 2011.
Bacterin's chairman and CEO, Guy Cook, and CFO, John Gandolfo, are scheduled to present on Thursday, September 8, 2011 at 9:10 a.m. Eastern time, with one-on-one meetings held throughout the day. Management will discuss the company's business plan and objectives for the remainder of 2011.
The presentation will be available via webcast at www.veracast.com/webcasts/stifel/healthcare2011/61203587.cfm. A replay link will also be available for 90 days following the live presentation on the company's website at www.bacterin.com.
Bacterin recently reported record revenue for the second quarter 2011 of $7.5 million, up 25% sequentially and 135% year-over-year. The company also reported its first positive EBITDA quarter of $33,000.
For more information about the conference or to schedule a one-on-one meeting with Bacterin management, contact your Stifel representative.
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin's Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further information, please visit www.bacterin.com.
Liolios Group, Inc.
Scott Liolios or Ron Both
|SOURCE Bacterin International Holdings, Inc.|
Copyright©2010 PR Newswire.
All rights reserved